268 related articles for article (PubMed ID: 3861240)
1. Specific protein phosphorylation in human promyelocytic HL-60 leukemia cells susceptible or resistant to induction of cell differentiation by phorbol-12-myristate-13-acetate.
Anderson NL; Gemmell MA; Coussens PM; Murao S; Huberman E
Cancer Res; 1985 Oct; 45(10):4955-62. PubMed ID: 3861240
[TBL] [Abstract][Full Text] [Related]
2. Cell-free system studies on the phosphorylation of the 17,000-20,000 dalton protein induced by phorbol ester in human leukemic cells and evidence for a similar event in virally transformed murine fibroblasts.
Feuerstein N; Nishikawa M; Cooper HL
Cancer Res; 1985 Jul; 45(7):3243-51. PubMed ID: 3159476
[TBL] [Abstract][Full Text] [Related]
3. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
4. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
Constantinou A; Henning-Chubb C; Huberman E
Cancer Res; 1989 Mar; 49(5):1110-7. PubMed ID: 2537141
[TBL] [Abstract][Full Text] [Related]
5. Differential phosphorylation events associated with phorbol ester effects on acceleration versus inhibition of cell growth.
Feuerstein N; Sahai A; Anderson WB; Salomon DS; Cooper HL
Cancer Res; 1984 Nov; 44(11):5227-33. PubMed ID: 6593117
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation.
Tonetti DA; Horio M; Collart FR; Huberman E
Cell Growth Differ; 1992 Oct; 3(10):739-45. PubMed ID: 1445803
[TBL] [Abstract][Full Text] [Related]
7. Rapid increase of the human IFN-gamma receptor phosphorylation in response to human IFN-gamma and phorbol myristate acetate. Involvement of different serine/threonine kinases.
Mao C; Merlin G; Ballotti R; Metzler M; Aguet M
J Immunol; 1990 Dec; 145(12):4257-64. PubMed ID: 2147939
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60.
Zylber-Katz E; Glazer RI
Cancer Res; 1985 Oct; 45(10):5159-64. PubMed ID: 3161611
[TBL] [Abstract][Full Text] [Related]
9. Changes in the patterns of protein phosphorylation associated with granulocytic and monocytic-induced differentiation of HL-60 cells.
Faille A; Poirier O; Turmel P; Chomienne C; Charron DJ; Abita JP
Anticancer Res; 1986; 6(5):1053-63. PubMed ID: 3467646
[TBL] [Abstract][Full Text] [Related]
10. Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation.
Cossu G; Kuo AL; Pessano S; Warren L; Cooper RA
Cancer Res; 1982 Feb; 42(2):484-9. PubMed ID: 6948606
[TBL] [Abstract][Full Text] [Related]
11. Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells.
Aquino A; Hartman KD; Knode MC; Grant S; Huang KP; Niu CH; Glazer RI
Cancer Res; 1988 Jun; 48(12):3324-9. PubMed ID: 3130982
[TBL] [Abstract][Full Text] [Related]
12. Double minute chromatin bodies and other chromosome alterations in human myeloid HL-60 leukemia cells susceptible or resistant to induction of differentiation by phorbol-12-myristate-13-acetate.
Au WW; Callaham MF; Workman ML; Huberman E
Cancer Res; 1983 Dec; 43(12 Pt 1):5873-8. PubMed ID: 6580064
[TBL] [Abstract][Full Text] [Related]
13. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
[TBL] [Abstract][Full Text] [Related]
14. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
15. Rapid phosphorylation-dephosphorylation of specific proteins induced by phorbol ester in HL-60 cells. Further characterization of the phosphorylation of 17-kilodalton and 27-kilodalton proteins in myeloid leukemic cells and human monocytes.
Feuerstein N; Cooper HL
J Biol Chem; 1984 Mar; 259(5):2782-8. PubMed ID: 6583202
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C activities with different characteristics, including substrate specificity, from two human HL-60 leukemia cell variants.
Homma Y; Gemmell MA; Huberman E
Cancer Res; 1988 May; 48(10):2744-8. PubMed ID: 3162823
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the formyl peptide chemotactic receptor appearing at the phagocytic cell surface after exposure to phorbol myristate acetate.
Gardner JP; Melnick DA; Malech HL
J Immunol; 1986 Feb; 136(4):1400-5. PubMed ID: 3511145
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells.
Chung TW; Choi HJ; Lee YC; Kim CH
Glycobiology; 2005 Mar; 15(3):233-44. PubMed ID: 15385432
[TBL] [Abstract][Full Text] [Related]
19. Effect of in vitro differentiation on phorbol diester receptor number in human promyelocytic leukemia (HL-60) cells.
Lane RW; Sturm RJ; Borzelleca JF; Carchman RA
Cancer Res; 1986 Aug; 46(8):3782-8. PubMed ID: 3460690
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by palmitoylcarnitine of adhesion and morphological changes in HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate.
Nakaki T; Mita S; Yamamoto S; Nakadate T; Kato R
Cancer Res; 1984 May; 44(5):1908-12. PubMed ID: 6324991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
